posted on 26 November 2008 2:15PM EST
Researchers at the University of Washington have updated a traditional Chinese medicine to create a compound that reportedly is more specific in killing certain kinds of cancer cells than currently available drugs, heralding the possibility of a more effective chemotherapy drug with minimal side effects. They published their results online October 5 in Cancer Letters.
The new compound puts a novel twist on the common anti-malarial drug artemisinin, which is derived from the sweet wormwood plant, which has been used in herbal Chinese medicine for at least 2,000 years, and is eaten in ...more.
posted on 26 November 2008 1:24PM EST
The victory of Rep. Henry A. Waxman over Rep. John Dingell for chairmanship of the House Energy and Commerce Committee has raised anxiety levels among analysts and money managers in the healthcare sector. When certain biotech and medtech stocks underperformed during last Friday’s stock market rally, some attributed it to the ascendancy of Waxman. Frequent GEN contributor Rod Raynovich reviews the pros and cons of Waxman’s appointment in this GEN blog.
Many of the concerns about Waxman’s appointment, who is often perceived as more liberal and less business friendly than Dingell, focused more ...more.
posted on 20 November 2008 5:15PM EST
Scientists from the Scripps Research Institute have discovered a catalytic antibody that degrades a known appetite stimulant. The antibody works against the gastric hormone ghrelin, which has been linked to weight gain and fat storage through its metabolic actions. These findings point toward a potentially novel treatment for obesity that would interfere directly with some of the biological mechanisms determining weight, according to the researchers.
During this week's podcast, Scripps' Dr. Kim Janda outlines his team's antibody experiment and talks about the research results in mice....more.
posted on 20 November 2008 8:57AM EST
Change is in the air
As we are all looking into a future free of attack-ads (for the next three years - give or take a few months) there are several things that are heartening about the incoming administration and the future of R&D in these here United States.
Just as a disclaimer, I am freely citing the Obama-Biden campaign's plan on these issues (link) and am adding my own two cents to it. One statement is particularly heartening: "Invest in the Sciences: Barack Obama and Joe Biden support doubling ...more.
posted on 19 November 2008 5:09PM EST
Posted by Ben Hewett on November 13, 2008 at 12:43 pm
The talk of the town since the conclusion of this historic election has been understandably focused on on how to fix the economy, pull out of Iraq over the next 16 months, and pursue clean energy alternatives. The magnitude of tasks that President-elect Obama has to contend with are staggering and each of them demand immediate action and long-term vision. However, through the fog of campaign rhetoric and economic meltdown in the US and in Europe, very little has been said about how the United States can take a real leadership position ...more.
pages: 1 2 3 4 5 6 7 8 9 10 11 >>
NOTICE: As such, the comments on this blog were, are, and will always be solely the opinions of the individuals leaving them. In no way does Genetic Engineering & Biotechnology News, GEN Publishing, Inc., or Mary Ann Liebert ,Inc. endorse, condone, agree with, sponsor, etc. these comments.
INTERVIEW:
CANCER-KILLING COMPOUND DEVELOPED FROM SALAD PLANT - Interview with Tomikazu Sasaki Ph.D., Associate Professor of Chemistry, University of Washington, and Co-Founder of Artemisia Biomedical, Inc.
...MORE
ADVERTISEMENT
NewsArticles Blogs| Most Viewed | Most Emailed | Top Searches |
|---|---|---|
| Corporate Social Responsibility | ||
| The Global Challenge of Infectious Disease | ||
| Will New Appointment “Wax” Healthcare Legislation? | ||
Subscribe to RSS
HOME
Hot Topics
All Topics
Archived
Post a Topic
RSS
Listen
Save
Comment